Listed

Xeriant, Inc.: Form 10-Q for the period ended Sep 30, 2022

Filed with the SEC on Nov 21, 2022 and accepted by EDGAR at Nov 21, 2022, 16:36 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2022-07-01 to 2022-09-30$0us-gaap:ResearchAndDevelopmentExpense
Operating income3 months2022-07-01 to 2022-09-30−$736.0kus-gaap:OperatingIncomeLoss
Interest expense3 months2022-07-01 to 2022-09-30$0us-gaap:InterestExpense
Net income3 months2022-07-01 to 2022-09-30−$4.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-07-01 to 2022-09-30−$0.01us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-07-01 to 2022-09-30−$0.01us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-07-01 to 2022-09-30361,552,863 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2022-07-01 to 2022-09-30−$565.3kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2022-07-01 to 2022-09-30$2.6kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2022-09-30$498.0kus-gaap:Cash
Current assetsAt period end2022-09-30$625.8kus-gaap:AssetsCurrent
Total assetsAt period end2022-09-30$749.9kus-gaap:Assets
Current liabilitiesAt period end2022-09-30$6.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-09-30$6.3mus-gaap:Liabilities
Shareholders' equityAt period end2022-09-30−$2.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001477932-22-008809. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.